Searched for
EXELON
US utilities spend big on rising data center demand, but affordability concerns loomThe largest US electric utilities are ramping up spending on new power infrastructure to meet surging demand from data centers, with compan...- US power companies increase data centre demand spending as DeepSeek fears waneThe notable upward revisions to capital investments suggest a continued rapid rise in data centre power consumption and dispel concerns tha...
- Microsoft deal signals booming demand from data centres to power AIUS utilities are securing lucrative power supply deals with data center operators amid surging AI-driven demand. Multiple agreements for gi...
- Microsoft deal signals booming demand from data centres to power AIUS utilities are securing lucrative power supply deals with data center operators amid surging AI-driven demand. Several companies, includi...
- US utilities signal booming demand from data centers as AI takes rootAmeren signed a supply deal with a data center with a power capacity of 250 megawatt (MW). It has also received expansion commitments and e...
- Talen asks US regulators to reject challenge to Amazon data center dealTalen Energy defends its Amazon data center deal against claims by utilities, stating it won't raise power costs or affect grid reliability...
- US election guide to markets: What to watch once it’s all overThe S&P 500 broke its longest losing streak in 36 years and regained most of what it had lost since the FBI reignited the e- mail controver...
- Aurobindo Pharma gets final USFDA nod for dementia drugDrug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Rivastigmine Tartrate Capsules USP.
- Investment in startups falls in recent weeksOnly one $50 million deal, of online pharmacy Netmeds, was announced in the last week of October.
- BSE to shift 11 firms to 'T' group; NSE 1 scripThe stocks would be transferred to the trade-for-trade segment or 'T' group with effect from August 25, NSE and BSE said in separate notifi...
- BSE to suspend trading in 26 securities from March 21BSE said it will suspend trading in shares of 26 companies for their failure to comply with various provisions of the exchange's listing ag...
- Alembic Pharmaceuticals soars on patent settlement case with NovartisShares of Alembic Pharma surged by over 4% after the co said it along with Breckenridge Pharma Inc, USA has settled a patent case with Nova...
- Citigroup puts 'hold' on Sun PharmaWhile Sun is entitled to 180 days exclusivity, thanks to the long delay in getting approval and full genericisation of the capsule form lik...
- DRL, Novartis smoke peace pipe on Alzheimer's drugDr Reddy’s Laboratories (DRL) has entered a settlement agreement with Novartis Pharma to suspend the launch of its generic capsule rivastig...
- Sun settles patent row with NovartisSun Pharmaceutical Industries has reached an out-of-court settlement with Novartis in the United States with regard to a patent dispute ove...
- Sun, Novartis settle Exelon drug disputeSun Pharmaceutical has reached an out-of-court settlement with Novartis in the US with regard to a patent dispute over the Swiss drug major...
- Sun Pharma settles Exelon patent case with NovartisSun Pharmaceuticals will now be selling generic version of Exelon in the US after Novartis dropped patent infringement lawsuit against it o...
- Sun Pharma gets US nod for Novartis' ExelonSun Pharma said it has won a 180-day marketing exclusivity for its version of Novartis' $200-million drug Exelon in the US.
- Sun Pharma receives USFDA nod for generic drugPharma major Sun Pharmaceutical Industries on Tuesday said it has received the final approval from the US Food and Drug Administration (USF...
- Regulatory hurdles may scuttle Exelon’s Public Service buyExelon said delays in winning regulatory approval in New Jersey may scuttle its $18.7bn acquisition of Public Service Enterprise Group, the...
Load More
